Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia

Full IRB Study Title:
AAML 1331, A Phase III Study for Patients with Newly Diagnosed Acute Promyelocytic Leukemia (APL) using Arsenic Trioxide and All-Trans Retinoic Acid: A COG Group wide Phase III Study

IRB Study ID: 150907

For complete information, please view the study on clinicaltrials.gov

Study Sponsor:

Children's Oncology Group; National Cancer Institute (NCI)

Akron Children‘s Anywhere Mobile App

Managing your child‘s health, made easier

Akron Children‘s Anywhere Mobile App

Managing your child‘s health, made easier

Akron Children‘s Anywhere is designed to be your “go-to app” for managing your child‘s health. It provides tools for finding a primary care doctor or specialist, finding locations and directions, and making everyday health decisions as well as giving you quick, secure access to MyChart and other tools. And when your child needs care, the renowned experts at Akron Children‘s are just one tap away.

Apple App Store Anywhere Mobile App Download Button

Google Play Anywhere Mobile App Download Button

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.